PODD News and Press, Insulet Corporation From 03/18/25

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Company will present results from its multinational Randomized Controlled Trial to Demonstrate the Efficacy of ...

2025-03-17 23:53:20 ET Summary PODD exhibits bullish price action with a series of higher highs and lows, trading above its upward sloping 30-week EMA since August 2024. Momentum is long-term bullish but short-term bearish, with the PPO line above zero indicating positive long-ter...

2025-03-16 09:05:34 ET More on Health Care Select Sector SPDR® Fund ETF XLV: With Relative Strength In January And Compelling Valuation, Health Care Earnings On Tap XLV: Buy Diversity And Growth Short bets against S&P 500 healthcare stock rises in Feb; MRNA ...

2025-03-12 13:43:09 ET More on S&P 500 Index: February CPI: A Happy Detour, But Unlikely To Last February CPI: Cool Headline Indexes Hide Mixed Underlying Data Cool February CPI Sparks A Stock Market Rebound, Volatility Remains High BlackRock expects upwa...

2025-03-12 10:01:00 ET Summary Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500® index. Stock selection and industry positioning contributed to...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will host an Investor Day at the Company's global headquarters in Acton, Massachusetts on Thursday, June 5, 2025. Presentations...

2025-03-09 09:05:09 ET More on Health Care Select Sector SPDR® Fund ETF XLV: With Relative Strength In January And Compelling Valuation, Health Care Earnings On Tap XLV: Buy Diversity And Growth Play defense with Goldman's cheap healthcare picks Notable ...

2025-02-22 01:23:55 ET Summary Insulet's Omnipod Insulin Management System has shown significant growth, with over 400,000 users using the system. The company reported strong results for 2024, accompanied by strong operating leverage. Insulet's valuation has surged after share...

2025-02-20 23:37:39 ET More on Insulet Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript Insulet Non-GAAP EPS of $1.15 beats by $0.13, revenue of $597.5M beats by $15.48M v Seeking Alpha’s Quant Rating on Insulet Historical earnings d...

2025-02-20 23:37:03 ET Insulet Corporation (PODD) Q4 2024 Earnings Conference Call February 20, 2025 16:30 ET Company Participants June Lazaroff - Senior Director of Investor Relations Jim Hollingshead - President & Chief Executive Officer Ana Chadwick - Exec...